Recent Posts on This Topic | See All >
Experimental cancer drug tested in Scottsdale shows promiseTags: cancer research, scottdale health care, tgen
[Source: Ken Alltucker, The Aizona republic] - An experimental cancer drug tested at Scottsdale Healthcare appears to shrink tumors in some skin cancer patients without significant side effects, local researchers said.
The experimental drug GDC-0449 showed promise in a phase-one trial, but it must be tested in more advanced trials with a larger group of patients to gauge the drug's effectiveness, they added.
It was used to test patients with advanced basal cell carcinoma, a rare type of skin cancer.
For more information: Experimental cancer drug tested in Scottsdale shows promise
Now available: “Action and Impact," a 2014 report on the grant programs and activities of the Flinn Foundation in Arizona biosciences, civic leadership, arts and culture, and the Flinn Scholars program.